fig1

Risk of cardio-nephro-metabolic disease from NAFLD to MAFLD: fact or fiction?

Figure 1. The proposed interplay between insulin resistance and NAFLD/MAFLD and subsequent development of diabetes, chronic kidney disease, and cardiac disease. NAFLD: Nonalcoholic fatty liver disease; MAFLD: metabolic associated fatty liver disease; ROS: Reactive oxygen species; BUN: blood urea nitrogen; RAAS: renin-angiotensin-aldosterone system; GGT: gamma-glutamyl transferase.

Metabolism and Target Organ Damage
ISSN 2769-6375 (Online)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/